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Summary
A central pathogenic feature of neurodegenerative dis-
eases and neurotrauma is the death of neurons. A
mechanistic understanding of the factors and condi-
tions that induce the dysfunction and death of neu-
rons is essential for devising effective treatment strat-
egies against neuronal loss after trauma or during
aging. Because Apolipoprotein E (ApoE) is a major
risk factor for several neurodegenerative diseases, in-
cluding Alzheimer’s disease [1], a direct or indirect
role of ApoE receptors in the disease process is likely.
Here we have used gene targeting in mice to investi-
gate possible roles of ApoE receptors in the regulation
of neuronal survival. We demonstrate that a differen-
tially spliced isoform of an ApoE receptor, ApoE re-
ceptor 2 (Apoer2), is essential for protection against
neuronal cell loss during normal aging. Furthermore,
the same splice form selectively promotes neuronal
cell death after injury through mechanisms that may
involve serine/threonine kinases of the Jun N-terminal
kinase (JNK) family. These findings raise the possibil-
ity that ApoE and its receptors cooperatively regulate
common mechanisms that are essential to neuronal
survival in the adult brain.
Results and Discussion
Apoer2 Protects against Neuronal Loss during Aging
To determine the role of Apoer2 in neuronal survival
in vivo, we used retrograde fluorescent-dye labeling
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7 These authors contributed equally to this work.of corticospinal neurons (CSN, Figure 1A) to monitor
neuronal loss during normal aging or after injury by
deafferation (Figure 1B) [2, 3]. We chose this method be-
cause it allowed us to determine whether reduction of
neurons during aging is caused by neuronal loss or by
decreased neurogenesis. We first determined whether
Apoer2 has any effects on the survival of intact adult cor-
ticospinal neurons (CSN) during aging (Figures 1C–1E).
Because Apoer2 is required for the control of neuronal
migration during the development of the brain [4], CSN
in Apoer22/2 mice are not located in cortical layer 5 as
they normally are in the wild-type but are instead aber-
rantly distributed in layers 4 and 6 (Figure 2A). The total
number of CSN is markedly reduced in 4-month-old
Apoer22/2mice (Figures 1C–1F and 2B), which could ei-
ther be caused by postnatal loss of CSN or be the result
of reduced neurogenesis in these animals. To distin-
guish between these possibilities, we counted baseline
CSN numbers at 1 month after birth, a stage at which de-
velopment of CSN is essentially complete [3, 5], and then
determined whether the number of cells labeled at this
early stage decreases in the Apoer2-deficient animals
over a 3 month period (Figure 1E). We found that at 1
month wild-type and Apoer22/2 mice have comparable
CSN numbers (Figures 1C–F and 2C). However, in 4-
month-old mice the number of CSN that had been
labeled at 1 month after birth was reduced by approxi-
mately 50% in the Apoer22/2 mice, whereas there was
no such age-dependent loss in the wild-type animals
(Figures 1C–1F and 2D). Thus, CSN are generated nor-
mally in Apoer22/2 mice but suffer accelerated cell
death during normal aging.
Neuronal Protection Is Mediated by the Alternatively
Spliced Exon 19
Neuronal death could either reflect an inherent Apoer2
survival-promoting function that might be dependent
on the extracellular signals that Apoer2 transmits across
the plasma membrane or, in the most trivial case, be
simply due to the CSN mislayering that occurs in
Apoer22/2 animals (Figure 2A). To distinguish between
these possibilities, we made use of knockin strains of
mice in which we had selectively altered the intracellular
domain of Apoer2 to prevent the receptor from interact-
ing with specific intracellular signaling pathways [6–8].
One of these knockin mouse lines lacks the binding
site for Dab1, a cytoplasmic adaptor protein that is re-
quired for activation of Src-family tyrosine kinases
upon exposure of neurons to the extracellular ligand
Reelin. This Apoer2 ligand controls neuronal migration
and positioning during embryonic brain development
[4], activates anti-apoptotic, and thus potentially
survival-promoting, signals [4, 9–12], and regulates syn-
aptic transmission through NMDA receptors [7, 13].
Another region of the Apoer2 cytoplasmic domain that
we have altered in another set of knockin strains con-
tains an alternatively spliced exon (exon 19) [7, 14] that
is not present in other LDL-receptor family members.
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2447Figure 1. Determination of Corticospinal Neuron Survival
(A) Schematic dorsal view of the mouse brain and cervical spinal cord showing CSN (blue triangles) labeled with TB injected into the corticospinal
tract (blue band) at the cervical spinal cord.
(B) Lesioned animals received an ICL that axotomizes CSN (red) one week after TB labeling. The wire knife used for the ICL is schematically de-
picted in the yellow frontal plane (right).
(C–F) Scoring of CSN survival in wild-type and Apoer2 knockout mice.
(C) Location of CSN in medial and lateral cortical areas. The medial area (red and blue) consists anteriorly of the medial prefrontal cortex (blue)
and posteriorly of the primary motor cortex (red). The lateral CSN area is located in the somatosensory cortex (green). CSN in the medial cortical
areas form a contiguous population with regard to their anterior-posterior distribution [2]. However, CSN of the medial prefrontal (blue in [D]) and
primary motor cortex (red in [D]) can be separated and are indicated as CSN numbers of each subpopulation peak in the center of the respective
areas. CSN of the somatosensory cortex are spatially separated from CSN of the medial areas.
(D) CSN in the medial cortical areas of wild-type and Apoer22/2 animals. In Apoer2 knockouts, CSN split into layer 4 CSN (black line) and layer 6
CSN (red line). Blue dotted line = sum of layer 4 and 6 CSN at the respective frontal levels. The data are from 4-month-old animals.
(E) CSN numbers at different postnatal stages depicted for the individual CSN areas (panel C) of wild-type (+/+; n = 10) and Apoer2 knockout
(2/2; n = 8) animals (total CSN numbers in all areas are shown in Figures 2B–2D). For determining whether the reduced CSN number in 4-month-old
knockouts (‘‘4 months,’’ see also Figure 2B) reflect death or altered neurogenesis, baseline CSN numbers were determined at one month (‘‘1
month’’), and CSN-survival assays were performed on 4-month-old animals that had received CSN tracing at one month (‘‘1+3 months’’).
One-month-old mice were chosen because CSN connectivity is complete at this age. 1 month: Apoer2 knockouts display slightly increased
CSN numbers in the primary motor cortex and reduced numbers in the other areas. The total number of CSN, however, is identical in wild-
type and Apoer22/2 animals (see also Figure 2C). 1+3 months: All CSN areas in Apoer2 knockouts have reduced CSN numbers, indicating
that CSN die in the absence of Apoer2 (for total CSN numbers, see Figure 2D). Statistical analysis of CSN survival was performed on total
CSN because individual subpopulations may be different in Apoer2 knockouts than in wild-type animals as a result of altered migration of
CSN in the mutants. Mean 6 SEM (all graphs). (F) The survival ratio of CSN in Apoer22/2 animals illustrates the fraction of CSN that survive in
Apoer2 knockouts between the first and fourth postnatal months. This ratio is comparable for all CSN subpopulations, which suggests that sim-
ilar mechanisms underlie neuronal survival and death.Exon 19 mediates the interaction of Apoer2 with Jun N-
terminal kinase (JNK)-interacting proteins (JIPs) and
with postsynaptic density protein 95 (PSD95) [7, 15, 16].
To determine the function of these regions and se-
quence motifs for CSN survival, we analyzed knockin
mice that exclusively express only one of the following
Apoer2 forms (Figure 3A): (i) Apoer2[long], a full-length
wild-type receptor containing both functional Dab1-
and JIP/PSD-binding regions [7]; (ii) Apoer2[short],
a truncated wild-type receptor containing the functional
Dab1-binding motif but lacking the JIP/PSD-binding
region [7]; (iii) Apoer2[Stop], a receptor that is truncated
downstream of the Dab1-binding motif and thus lacks
the JIP/PSD binding region and the rest of the cytoplas-
mic tail; and (iv) Apoer2[Dab2], a full-length receptor thatcontains the JIP/PSD-binding region but whose Dab1-
binding motif carries a mutation that prevents Dab1 in-
teraction and activation [6]. Analyses were performed
on 8-month-old animals. As expected, we found that
CSN were located correctly in layer 5 in animals ex-
pressing a functional Dab1-binding site (Apoer2[long],
Apoer2[short], and Apoer2[Stop]) but that they were
mislocalized to layers 4 and 6 if this site was inactivated
(Apoer2[Dab2]) (Figure 3B). However, the number of
CSN was not affected if only the Dab1-binding site
was mutated (Apoer2[Dab2]), indicating that mislocali-
zation alone did not impair neuronal survival. In contrast,
CSN numbers were reduced by approximately 36% if
the JIP/PSD-binding site was missing (Apoer2[short])
and even more so, by approximately 64%, when the
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2448Figure 2. Malpositioning of Layer V Neurons
and Age-Dependent Loss of Fluorescently
Labeled CSN during Aging in Wild-Type and
Apoer22/2 Mice
(A) Fluorescently (True Blue, TB)-labeled CSN
in wild-type and Apoer22/2 mice. Location of
cortical layers 4 (L4)–6 (L6) is indicated. The
scale bar represents 0.5 mm.
(B and C) Total CSN number at different
ages in wild-type and Apoer22/2 mice. 1+3
months: CSN were TB-labeled at 1 month,
and CSN survival was assessed 3 months
later. In the other groups, CSN numbers
were determined 1 week after tracing. Mean
6 SEM (all graphs). (B) Wild-type (wt): n = 6.
Apoer22/2: n = 6, p = 0.012. (C) wt: n = 10.
Apoer22/2: n = 8.
(D) wt: n = 8. Apoer22/2: n = 6, p < 0.01.JIP/PSD-site including the distal cytoplasmic tail was
absent (Apoer2[Stop]) (Figure 3C). Thus, CSN survival
promotion by Apoer2 requires the Apoer2 tail’s
carboxy-terminal sequences that interact with JIPs
and PSD95, but these are not essential for neuronal mi-
gration. The apparently normal and indistinguishable
neuroanatomy of Apoer2[long], Apoer2[short], and
Apoer2[stop] animals makes it further unlikely that the
striking protection of the animals lacking exon 19 from
lesion-induced neuronal death (see below, Figure 4)
could be caused by differences in axonal pathfinding
during development when the axons of exon-19-lacking
mice would otherwise have to selectively circumnavi-
gate the site of future lesion induction.
The age-dependent reduction in CSN numbers in the
Apoer2[short] and Apoer2[Stop] is accompanied by
a significant reduction in thickness of the primary motor
cortex (Figure 3D), and this finding is consistent with
the occurrence of widespread neuronal loss in these
animals. In addition to accelerated neuronal cell loss,
we also found prominent lipofuscin autofluorescence
in the neocortex, entorhinal cortex, basal nucleus of
Meynert, and hippocampus of the Apoer2[short] and
Apoer2[Stop] animals (Figure 3B). Lipofuscin deposits
are a general indicator for degenerative processes in
the CNS, independently supporting the presence of
accelerated neuronal loss in these mutants.
Role of Exon 19 in Lesion-Induced Neuronal Loss
The prominent and splice-form-specific role of Apoer2
for the survival of intact CSN led us to investigate
whether Apoer2 would also affect the survival of neu-
rons after injury. To investigate this, we chose a model
in which CSN are mechanically damaged by stereotaxic
deafferentation at the level of the internal capsule [2]
(Figure 1B). Neurons were retrogradely labeled 7 days
before deafferentation, and 1-month-old animals were
used because CSN numbers are equivalent for all geno-
types at this age (Figure 2). Consistent with previous
findings, 40% of the injured CSN died in wild-type ani-
mals [2], whereas CSN of Apoer22/2mice were resistant
to injury-induced death (Figure 4A, left panel). Similar
survival ratios (normalized to the unlesioned side) wereobtained in 4-month-old Apoer2 knockout animals, indi-
cating that all neurons that have survived to this age are
equally protected from lesion-induced death in the ab-
sence of Apoer2 (Figure 4A, right panel). To determine
whether the Dab1- or JIP-binding sites in Apoer2 are in-
volved in injury-induced neuronal death, we assessed
CSN survival in 4-month-old Apoer2[long], Apoer2
[short], and Apoer2[Dab2] mice (Figure 4B). At this time
point, age-dependent loss of CSN was not yet promi-
nent in Apoer2[short] animals, and the total number of
CSN in uninjured knockin animals was not significantly
different from that in the wild-type. As was the case for
survival in the uninjured state, injury-induced death did
not depend on the Dab1 site but rather depended on
the intracellular region that contains the PSD/JIP bind-
ing-sites (Figure 4B and 4C), with approximately 40%
lesion-induced neuronal loss occurring in mice express-
ing the exon 19 sequences. By contrast, lesion-induced
cell death was completely prevented when this exon
was absent. These data suggest that the domain that re-
cruits JIP/PSD95 in Apoer2 is critical for regulating sur-
vival not only during the aging process but also after
traumatic injury to the brain.
Injury-Induced CSN Death Is Prevented in JNK3
Knockout Mice
Among the adaptor molecules that are recruited to
Apoer2 exon 19, the JIPs are of particular interest
because they can also bind JNK and thus serve as a
scaffold for the assembly of potentially death-promoting
kinases on the Apoer2 intracellular domain. JIP1 and
JIP2 isoforms only bind to Apoer2 receptors containing
this exon (Figure 4D). JNK3 in particular is preferentially
activated in neuronal lesions [17, 18], and this isoform
interacts specifically with one of the JIP1 isoforms that
binds to exon 19 of Apoer2 (Figure 4E). The total number
of labeled CSN was not different in 4-month-old unin-
jured wild-type and JNK32/2 mice (littermate controls
were used; data not shown). However, CSN did not die
after lesions in JNK3 knockout mice (Figure 4F), as had
also been seen in previous work where JNK3-null neu-
rons showed three times higher survival rates after is-
chemic challenge than did wild-type neurons [19]. Taken
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which the long isoform of Apoer2 mediates the assem-
bly of JNK signaling complexes at the neuronal mem-
brane, from where they may be released and become
death promoting upon injury. Because the same exon
also mediates the functional interaction of Apoer2 with
NMDA receptors [7, 20], we cannot exclude an NMDA-
receptor-mediated excitotoxic component that might
contribute to the observed increased cell death after
injury in those mice in which exon 19 is present. Like-
wise, because Apoer2 exon 19 potently increases neu-
ronal plasticity through the same mechanisms, loss of
this function might contribute to the age-dependent
neuronal cell loss that we have observed in mutant
mice lacking this exon.
Our study shows that the ApoE receptor Apoer2 reg-
ulates the survival of adult neurons and that this involves
a specific role of the cytoplasmic exon 19 of Apoer2,
which recruits JIP1-JNK3 complexes. Activation of
Dab1 is not required for the regulation of neuronal sur-
vival, despite the fact that the Dab1-binding site is re-
quired for activating survival-promoting kinases [21],
such as PI3-kinase and Akt [6, 11]. Thus, the exon-19-
containing forms of Apoer2 may restrict a population
of JNK complexes to the plasma membrane, where
they probably participate in the modulation of signals
through Apoer2 under normal conditions. In the absence
of Apoer2 or its exon-19-containing form, redistribution
of this population may chronically increase the activity
of a different, cell-death-promoting pool. This hypothe-
sis is consistent with earlier findings by Nimpf, Baier,
and colleagues [22], who showed that LRP1, another
LDL-receptor gene family member that also interacts
with JIP/JNK complexes, can also sequester JNK at
the plasma membrane through its intracellular domain
and thereby potently reduce cell death. Our results
now suggest that a similar mechanism may apply to
the neuronal survival-promoting role of Apoer2 in vivo,
explaining the progressive neuronal loss we have ob-
served in our aging animals. Apoer2 undergoes regu-
lated intramembraneous proteolysis (RIP) [23], and neu-
ronal injury induces intracellular as well as extracellular
Figure 3. Neuronal Degeneration in Apoer2 Knockin Mutant Strains
(A) Receptor isoforms expressed by Apoer2 knockin mutant mice.
PSD95 and JIPs interact with sequences within exon 19 (blue).
These sequences are absent in Apoer2[short] and Apoer2[Stop].
The Dab1 binding site is indicated by the asterisk (*). Mutation of
this site in Apoer2[Dab2] abrogates binding.
(B) Left panels: TB-labeled CSN in the indicated mouse strains. The
scale bar represents 0.5 mm. Right panels: CSN (DAPI-filter) and lip-
ofuscin deposits (FITC-filter) at higher magnification (from boxed
areas at the left side). The scale bar represents 50 mm. Labeled
CSN are present in layer 5, except in Apoer2[Dab2], where they
are misplaced to layers 4 (top) and 6 (dispersed cell population in
bottom part of the image).
(C) CSN number in wt (n = 8), Apoer2[long] (n = 6), Apoer2[short] (n =
8), Apoer2[Stop] (n = 10), and Apoer2[Dab2] (n = 6) animals. Apoer2
[short] and Apoer2[Stop] versus others, p < 0.001 (ANOVA). Post hoc
Newman-Keuls-test: * = p < 0.05, ** = p < 0.01. Error bars represent
SEM.
(D) Representative coronal sections through the primary motor cor-
tex in the indicated mouse strains. The thickness of the cortex is sig-
nificantly reduced in mice lacking exon 19. The age of animals was 8
months (B–D).
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main of Apoer2 Mediates Injury-Induced Neuronal Cell Death
Death of CSN by deafferentation is complete within the first 5 days
after lesion induction [26]. CSN survival was thus assessed after 7
days. Deafferentation was performed on one side only; the contra-
lateral unlesioned side served as a control (Figure 1B). Numbers of
surviving CSN on the ipsilateral side were compared to those on
the contralateral, unlesioned side.
(A) Lesion-induced CSN death is prevented in 1-month-old and 4-
month-old Apoer22/2 mice (**indicates p < 0.01). L4 = layer 4 CSN,
L6 = layer 6 CSN. Four wt and three Apoer22/2 were analyzed.
(B) Lesion-induced CSN death in 4-month-old Apoer2[Dab2]
and Apoer2[long] animals is similar to that in wild-type animals.
In contrast, lesion-induced death is completely prevented in
Apoer2[short] animals (p < 0.05). n values: 4 (wt), 3 (Apoer2[long]),
5 (Apoer2[short]), and 3 (Apoer2[Dab2]).
(C) CSN in Apoer2 knockin mice. The scale bar represents
0.5 mm.proteolysis (reviewed in [24]). Although the data we have
presented do not provide definitive proof, the seemingly
paradoxical ‘‘death-promoting’’ effect of the exon-19-
containing forms of Apoer2 could be explained by
a model in which an accelerated proteolytic release of
Apoer2-bound JNK complexes from the plasma mem-
brane in the wake of neuronal injury acutely increases
soluble cytoplasmic or nuclear-death-promoting kinase
activity. This would not occur in the absence of exon 19.
Intriguingly, the ApoE genotype has only been associ-
ated with neurological disorders that manifest them-
selves during midlife and senescence or after neuronal
injury. It is tantalizing to speculate that this isoform-
selective effect of ApoE manifests itself through the
receptors to which it binds, possibly by a differential
impact on neuronal JNK signaling. The data we have
presented here thus suggest a novel mechanism by
which the ApoE receptor Apoer2 can mediate age-
dependent and injury-induced neurodegeneration. This
may also be relevant to the pathogenesis of Alzheimer’s
disease.
Experimental Procedures
Mouse Models
Apoer22/2 [4], Apoer2[Dab2] [6], Apoer2[long] [7], Apoer2[short] [7],
and JNK32/2 [17] mutant mouse strains have been described previ-
ously. Apoer2[long] and Apoer2[short] have previously been referred
to as Apoer2 ex19 and Apoer2 Dex19, respectively [7]. To generate
Apoer2[Stop] mutants, a premature Stop signal (Glu904Stop) was
introduced by site-directed mutagenesis (Stratagene, La Jolla, CA)
on a 434 bp cDNA encoding the Apoer2 intracellular domain (ICD)
5 amino acids downstream of the NFDNPVY sequence, which is nec-
essary for Dab1 binding. This removes a portion of exon 18, and all of
exons 19 and 20, and thus creates a new carboxy terminus. The
primers used for mutagenesis were as follows: Glu904Stop-fwd,
50-CAGTGTACAGGAAAACGACATAAGAGGAAGAGGAAGATGAG-30
and Glu904Stop-rev, 50-CTCATCTTCCTCTTCCTCTTATGTCGTTTT
CCTGTACACTG-30. The mutant cDNA fragment was inserted into
a genomic fragment containing Apoer2 exons 9–16. Further cloning,
embryonic stem cell screening, and selection were carried out as
previously described [7].
Surgical Procedures
All protocols involving the use of animals for the following experi-
ments were in compliance with the National Institutes of Health’s
Guide for the Care and Use of Laboratory Animals and the UT South-
western Animal Care and Use Committee. CSN were labeled with the
retrograde fluorescence tracer True Blue (TB) [2, 25] injected at the
C4/C5 cervical spinal cord levels of the corticospinal tract (CST)
(Figure 1A). ‘Survival time’ of intact animals after tracing was 7
days. To determine the rate of survival of injured neurons, lesions
were induced one week after TB-labeling by stereotaxic unilateral
axotomy of the internal capsule using a KOPF wire knife (Figure 1B)
(D) Exon-19-encoded sequences interact with JIP1, JIP1b, and
JIP2. Proteins were expressed in HEK 293 cells and immunopre-
cipitated with the indicated antibodies.
(E) JIP-JNK3 coimmunoprecipitation assays show that JIP1 inter-
acts with JNK3.
(F) JNK3 signaling is required for death induction of lesioned CSN.
Lesion-induced death is prevented in JNK32/2 animals. Averages
and SEM are shown and were determined by a Student’s T-test,
p = 0.005 (**) between wt (n = 7) and JNK32/2 (n = 10).
(G) Photomicrographs of TB-labeled CSN after lesions from repre-
sentative JNK32/2 and wild-type animals. Labeled CSN are pres-
ent in layer 5, except in Apoer2[Dab2], where they are misplaced
to layers 4 (top) and 6 (dispersed cell population in the bottom
part of the image). The scale bar represents 0.5 mm.
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described below.
Tissue Preparation for Survival Assays
Tissue preparation was carried out as described previously [2]. In
brief, the mice were deeply anesthetized and transcardially perfused
with PBS followed by 4% paraformaldehyde in PBS. Brains were
postfixed for 2 hr, cryoprotected overnight in 25% sucrose solution
in PBS, and frozen in isopentane. Serial cryostat sections (20 mm)
were obtained throughout the entire cortex [2], and every second
section was collected for cell counts; the remaining sections were
used for histological evaluation.
Quantitation of Corticospinal Neurons
Cell counts were determined with a stereological approach in which
the total number of CSN in the entire cortex was assessed [2]. Using
every fourth section, we designated positive CSN as TB-filled pyra-
midal neurons at least 3 mm in diameter. We verified that CSN size
did not affect CSN number by comparing the stereological approach
described here to an optical-dissector method [2]. CSN within a spe-
cific cortical area were defined by their stereotaxic coordinates. The
quantification procedures for intact and lesioned CSN were essen-
tially identical [2], except as follows:
Lesioned CSN: Axotomy as described above is generally com-
plete for the primary motor cortex, whereas some CSN are usually
spared in other cortical areas [2]. Thus, only primary motor cortex
was scored. The lesion area was determined by the absence of
a second tracer (rhodamine dextran) that was applied to the cervical
corticospinal tract after axotomy [2]. Within the primary motor cortex
(posterior peak in Figure 1D), a ‘‘cell-death area’’ (cda) was defined
according to two constant anatomical criteria [2]: (i) The cda begins
anteriorly at the level of the anterior commissure and extends
1.6 mm posteriorly; and (ii) in the anterior-posterior direction, the cda
is located within the central 50% of the primary motor cortex. Within
the cda, percent survival was calculated as (number of TB-labeled
CSN on the lesion side/number of TB-labeled CSN contralateral to
the lesion side) 3 100%.
Intact CSN: The data of unlesioned CSN are shown as absolute
CSN numbers acquired per cortical hemisphere. The survival assays
are based on a total of 800,000 CSN counted.
ApoER2-JIP-JNK Binding Assays
HEK293 cells were transiently transfected (FuGENE transfection re-
agent) with mouse ApoER2 tails with or without exon 19 in
p3XFLAG-CMV-9 and either JIP1 (pcDNA3), JIP1b (pcDNA3), or
JIP2 (pCMV-5Xmyc). The lysates from the transfected cells were
pre-cleared with nonimmune rabbit antibody, and ApoER2 was
immunoprecipitated with a C-terminal ApoER2 antibody (a-CT-
ApoER2). Immunoprecipitates were separated on SDS-PAGE, trans-
ferred to nitrocellulose, and blotted with monoclonal JIP1 antibody
(Santa Cruz Biotechnology: recognizes both JIP1 and JIP1b) or
Myc antibody (JIP2). JNK3 (in p3XFLAG-CMV-9) was immunopre-
cipitated from noncleared lysates with a polyclonal FLAG antibody.
JIPs were detected with Myc antibody (9E10).
Statistics
For each animal, the absolute number of CSN and ratios (survival of
CSN on the lesion side relative to the control side) were calculated
with Microsoft Excel and analyzed with SigmaStat software by
one-way analysis of variance (ANOVA) followed by the post-hoc
Newman-Keuls-test. In addition, single pair-wise comparisons
were performed with the Student’s t test.
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